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Abstract
Sequence type (ST) 59 is an epidemic lineage of community-associated (CA) methicillin-resistant Staphylococcus aureus
(MRSA) isolates. Taiwanese CA-MRSA isolates belong to ST59 and can be grouped into 2 distinct clones, a virulent Taiwan
clone and a commensal Asian-Pacific clone. The Taiwan clone carries the Panton–Valentine leukocidin (PVL) genes and the
staphylococcal chromosomal cassette mec (SCCmec) VT, and is frequently isolated from patients with severe disease. The
Asian-Pacific clone is PVL-negative, carries SCCmec IV, and a frequent colonizer of healthy children. Isolates of both clones
were characterized by their ability to adhere to respiratory A549 cells, cytotoxicity to human neutrophils, and nasal
colonization of a murine and murine sepsis models. Genome variation was determined by polymerase chain reaction of
selected virulence factors and by multi-strain whole genome microarray. Additionally, the expression of selected factors was
compared between the 2 clones. The Taiwan clone showed a much higher cytotoxicity to the human neutrophils and
caused more severe septic infections with a high mortality rate in the murine model. The clones were indistinguishable in
their adhesion to A549 cells and persistence of murine nasal colonization. The microarray data revealed that the Taiwan
clone had lost the ø3-prophage that integrates into the b-hemolysin gene and includes staphylokinase- and enterotoxin P-
encoding genes, but had retained the genes for human immune evasion, scn and chps. Production of the virulence factors
did not differ significantly in the 2 clonal groups, although more a-toxin was expressed in Taiwan clone isolates from
pneumonia patients. In conclusion, the Taiwan CA-MRSA clone was distinguished by enhanced virulence in both humans
and an animal infection model. The evolutionary acquisition of PVL, the higher expression of a-toxin, and possibly the loss
of a large portion of the b-hemolysin-converting prophage likely contribute to its higher pathogenic potential than the
Asian-Pacific clone.
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Introduction
Community-associated methicillin-resistant Staphylococcus aureus
(CA-MRSA) strains are very successful pathogens that emerged in
the late 1990s and spread throughout the world within a few years
[1,2]. The strains can be isolated from the skin and mucosa of a
substantial proportion of healthy individuals and are capable of
causing disease, including lethal infections [3–5]. Currently, CA-
MRSA strains have outnumbered methicillin-susceptible S. aureus
strains as the dominant community pathogen in many areas of the
world [6,7]. Epidemic CA-MRSA clones vary in different
continents, countries, and even areas. For example, pulsed-field
type USA300 (sequence type 8, ST8) and USA400 (ST1) are the
major clones in the United States and Canada [8,9]; ST80 clones
are prevalent in Europe [10–12]; ST59 clones circulate in the
Asian-Pacific area, including Taiwan and Australia; and ST30
clones are found worldwide, including the USA, Europe, Oceania,
and Japan [13–17]. These 5 clones account for the majority of
CA-MRSA infections worldwide. It is essential to elucidate the
determinants contributing to the transmission and/or virulence of
epidemic CA-MRSA clones.
Our previous molecular epidemiology studies in Taiwan on
clinical and carriage isolates of CA-MRSA revealed that 2 major
genotypes accounted for the majority of CA-MRSA strains [7,18].
These were designated as a ‘‘Taiwan’’ clone and an ‘‘Asian-
Pacific’’ clone, and were differentiated by pulsed-field typing. In
addition, isolates of the Taiwan clone carried the type VT SCCmec
element and the Panton–Valentine leukocidin (PVL) genes, while
isolates of the Asian-Pacific clone typically carried a type IV
SCCmec element and lacked the PVL genes [17]. Isolates of both
pulsotypes had a similar genetic background and belonged to the
ST59 lineage. Severe infections were caused by the Taiwan clone
(ST59-MRSA-VT-PVL-positive), although the Asian-Pacific clone
(ST59-MRSA-IV-PVL-negative) was more prevalent in colonizing
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healthy individuals. In a carriage surveillance study of MRSA in
2001–2002, 78.3% of colonizing isolates belonged to the Asian-
Pacific clone [19]. Another MRSA nasal carriage surveillance
study in healthy Taiwanese children from 2005–2006 revealed
that 62% of isolates belonged to the Asian-Pacific clone and 28%
to the Taiwan clone [20]. In contrast, 73% of CA-MRSA
infections in Taiwanese children were caused by the Taiwan clone
in a prospective study during 2004–2005 [7]. Strains carrying type
VT SCCmec elements (presumed to be the Taiwan clone)
constituted 71.1% of clinical isolates of MRSA with CA
characteristics in an additional island-wide survey [21].
The above epidemiological observations suggest a greater
virulence for the Taiwan clone as compared to the Asian-Pacific
clone. The respective abundance of the 2 related clones in
colonizing strains and infecting strains provided an excellent
opportunity to explore the factors implicated in CA-MRSA
pathogenesis. To achieve this goal, we first compared the
phenotypes of the 2 clones, including the ability to colonize and
infect, by using murine models. Second, the genetic compositions
of the 2 clones were delineated by polymerase chain reaction
(PCR) screening of selected virulence genes and by comparative
genomics using a DNA microarray. The genomic study also
helped to elucidate the evolutionary history of the ST59 strains.
Finally, the expression of virulence genes most likely to be
contributing factors to the pathogenesis of CA-MRSA was
analyzed and compared between the 2 clones.
Results
Adhesive Assay and Murine Colonization Study
A comparison of 15 CA-MRSA isolates of ST59 lineage (Table 1
and Figure 1) belonging either to the Asian-Pacific clone or
Taiwan clone revealed no differences in growth rate or biofilm
production (Figure S1a–c). Susceptibility to various non-b-lactam
antibiotics was also similar for the 2 clones, although tetracycline
was an exception because the Taiwan clones were more frequently
resistant to it than the Asian-Pacific clones (100% vs. 42.9%,
p=0.026; Figure S1d).
The predominance of the Asian-Pacific clone in CA-MRSA
carriage may be due to the higher colonizing ability of this clone
than the Taiwan clone. To test this hypothesis, adherence to
respiratory epithelium cells (A549) was determined and compared
between 2 representative strains (SA40 and SA957) belonging to
the Asian-Pacific clone and Taiwan clone, respectively. The assay
was validated by showing a significant defect in adherence using
the SA113 strain containing a tagO-deletion, a factor essential for
nasal colonization (Figure 2a). The adherence to A549 cells was
similar for both SA40 and SA957. Colonization ability was further
tested in vivo in a murine nasal carriage model. After 7 days of
instillation, the colony counts of bacteria recovered from the nose
of mice were not significantly different between SA40 and SA957
(Figure 2b). These results failed to support the hypothesis that
greater colonization ability was responsible for the abundance of
the Asian-Pacific clone in CA-MRSA carriage isolates. However,
these colonization assays were carried out using a human alveolar
basal epithelial cell line and a murine nasal carriage model, which
might not be equivalent to human nasal carriage.
Cytotoxicity Assay and Infectivity in Murine Sepsis Model
To evaluate the virulence of the Asian-Pacific clone and Taiwan
clone, the cytotoxicity of an overnight culture supernatant to
human PMN cells was determined using 15 ST59 CA-MRSA
isolates (Table 1 and Figure 1). Isolates carrying the PVL genes
(mainly the Taiwan clone) had a higher cytotoxicity to human
PMN cells than did isolates of the PVL-negative Asian-Pacific
clone, although this did not reach statistical significance
(p=0.0879; Figure 3). The cytotoxic effect on neutrophils
correlated well with the amount of PVL in the culture supernatant
(Figure 3).
To further evaluate the virulence of the 2 epidemic represen-
tatives, SA40 (Asian-Pacific clone) and SA957 (Taiwan clone) were
injected into the bloodstream of 2 groups of mice treated with
either a lethal (56107 colony-forming units, CFU) or with a non-
lethal (56106 CFU) dosage of bacteria. Mortality after 48 h was
not significantly different for mice infected with lethal dosages of
SA957 (100%) and SA40 (75%, p=0.467; Figure 4). However, all
deaths in the SA957-infected mice occurred within 24 h of
infection. Mice infected with SA40 had a longer survival time as
shown by Kaplan–Meier survival analysis (p,0.001; Figure 4a). A
greater virulence of SA957 was also indicated by significantly more
body weight loss and bacterial loads in various internal organs of
mice infected with non-lethal dosages of SA957 than with SA40
(Figure 4b–4d).
Comparative Genomics
To further explore the determinants of virulence of the 2
epidemic CA-MRSA clones, we determined pulsotypes in a
random sample of 82 clinical CA-MRSA strains from Taiwanese
children during 2003–2007. The strains were further screened for
the presence of genes encoding 10 superantigens (SEA-SEE,
TSST-1, and SEG-SEJ), 2 exofiliatin toxins (ETA and ETB), 2
cytolysins (PVL and c-hemolysin), 4 adhesion proteins (FnbA,
SdrE, cna and icaA), arginine catabolic mobile elements (ACME),
and SCCmec types by PCR (Figure 5). As expected, there was a
strong association between clonality (pulsotypes) and SCCmec
types. The majority (91.9% of 62 isolates) of Taiwan clones carried
type VT SCCmec whereas 12 (100%) isolates of the Asian-Pacific
clone carried type IV SCCmec (p,0.0001, Fisher’s exact test). All
isolates of both the Taiwan clone and the Asian-Pacific clone were
negative for cna and ACME genes as well as most of the screened
cytotoxins with the exception of enterotoxin B, PVL, and c-
hemolysin. Enterotoxin B and c-hemolysin were identified in 66
(89.2%) and 52 (70.3%) isolates, respectively. The presence of
enterotoxin B, c-hemolysin, and genes encoding adhesion proteins
such as FnbA, SdrE, and icaA did not differ significantly between
the 2 epidemic clones of ST59. PVL genes were harbored by 64
(86.5%) of 82 isolates and were identified significantly more often
in the Taiwan clones (98.4%) than in the Asian-Pacific clones
(25.0%, p,0.0001).
To obtain more information of the genetic compositions of the 2
epidemic ST59 clones, we conducted comparative genomics with
14 CA-MRSA strains of ST59 lineage (Table 1 and Figure 1) by
using a microarray containing 3,626 open reading frames (ORFs).
The array data can be accessed in ArrayExpress (accession
number E-MEXP-3627). The microarray analysis clustered the 14
CA-MRSA strains into 2 groups, consistent with the grouping of
the pulsed-field pattern. Among the 3,626 ORFs in the gene chip,
2,984 (82.3%) were present in at least 6 of 7 Taiwan clone isolates
and 2,840 (78.3%) were present in at least 6 of 7 Asian-Pacific
clone isolates. Three ORFs, encoding hypothetical proteins and
phage integrase, were specific to the Taiwan clone (Table S1).
Twenty-eight ORFs were specific for colonizing strains (Table S1),
which included 22 genes on a b-hemolysin-converting prophage
(øSa3 in MRSA252), 5 SCCmec-associated genes, and 1 gene of
unknown function on core genome. The microarray hybridization
data for the 14 strains of CA-MRSA were visualized using the
bacteriophage øSa3 genome in MRSA252 (Figure 6). It showed
that most of the genes in øSa3 were present in isolates of the Asian-
Comparison of CA-MRSA ST59 Clones
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Pacific clone, but 2 segments (dark-colored blocks) were missing in
the isolates of the Taiwan clone. The missing segment included
genes such as sak (encoding staphylokinase) and sep (encoding
enterotoxin P).
Expression of Selected Global Regulators and Virulence
Factors
The expression of RNAIII, srrA, and saeRS, as well as 3 important
virulence factors (a-hemolysin, phenol-soluble modulins-a (PSM-
a), and protein A) were compared between 11 isolates of the 2
epidemic clones, which included 5 Taiwan clone isolates and 6
Asian-Pacific clone isolates (Figure 7c). The expression of protein
A, PSM-a, and global regulators, including RNAIII, SrrA, and
saeRS, was not significantly different between the 2 clones
(Figure 7a–b). The a-toxin was produced at higher levels in 4 of
the 5 Taiwan clone strains than those of the Asian-Pacific clone,
but this did not reach statistical significance (Figure 7a and 7c).
Interestingly, all 4 strains producing high levels of a-toxin were
PVL-positive and were isolated from children with severe CA-
MRSA pneumonia. The other 2 PVL-positive strains with low
levels of a-toxin production were either a nasal isolate (strain 571)
or a wound culture isolate (strain 2851) (Figure 7c).
Discussion
Nasal colonization of S. aureus is a known risk factor for the
development of subsequent S. aureus diseases in selected popula-
tions. Data from previous epidemiology studies have suggested
that carriage of S. aureus strains with certain characteristics (e.g.,
harboring PVL genes, methicillin resistance) was associated with
increased risk of subsequent infections [22,23]. The epidemic
surveillance data of CA-MRSA in Taiwan was in agreement with
previous observations and strongly suggests that a PVL-positive
clone, i.e., the Taiwan clone, had a greater potential of causing
severe disease as compared to its sister clone, the PVL-negative
Asian-Pacific clone. The epidemiologic observation was supported
by the results of the current study, which showed that there was an
increased pathogenic potential for the Taiwan clone in both an
in vitro human PMN cytotoxicity assay and an in vivo murine sepsis
model.
We were not successful in identifying molecular determinants
that would account for the increased virulence of the Taiwan clone
in microarray study. The genome-wide comparison disclosed only
very subtle differences in genetic compositions between the 2
clones. The Taiwan clone did not harbor any extra known
virulence determinants, with the exception of PVL genes, in
comparison to the Asian-Pacific clone. Given the inherent
limitations of the DNA microarray, some virulence factors may
Figure 1. Genotypes of 15 CA-MRSA strains used in the current study. *ST338 is a single locus variant of ST59 Abbreviations: MLST, multi-
locus sequence type; SCCmec, staphylococcal chromosomal cassette mec; PFGE, pulsed-field gel electrophoresis; PVL, Panton–Valentine leukocidin;
TW, Taiwan clone; AP, Asian-Pacific clone.
doi:10.1371/journal.pone.0063210.g001
Comparison of CA-MRSA ST59 Clones
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not have been readily identified. However, we believe that this is
unlikely due to preliminary results of whole genome sequencing of
the 2 representative strains, SA957 (Taiwan clone, accession
number CP003603, GenBank) and SA40 (Asian-Pacific clone,
accession number CP003604, GenBank) showing very similar
findings to that of the microarray data (Prof. Cheng-Hsun Chiu,
unpublished data). The failure to identify Taiwan clone-specific
virulent determinants other than PVL might suggest a potential
role of PVL in the pathogenic success of the Taiwan clone.
Nevertheless, small genetic variations such as single nucleotide
polymorphisms resulting in non-synonymous mutations are very
difficult, if not impossible, to be captured by DNA microarray
analysis. Single nucleotide alterations can have a major impact on
the function of the affected alleles and may be contributing to the
Table 1. Characteristics of CA-MRSA strains used in the current study.
Strain name Characteristics of isolates Characteristics of host Reference
Source Origin Year Age (y)/sex Pneumonia Other clinical symptoms
SA957 Blood NT 2000 16.4/Male + Bacteremia, arthritis, cutaneous
abscess
[4]
2851 Abscess NT 2001 16.1/Male 2 Cutaneous abscess, shock [4]
4860 Blood NT 2001 13.3/Male + Bacteremia, arthritis [4]
sta703 Blood NT 2007 11.8/Male + Bacteremia, pyomyositis, deep
venous thrombosis, ICH
Current study
44 Blood NT 2004 11.2/Female + Bacteremia, arthritis, osteomyelitis,
pyomyositis
[4]
4950 Pleural fluid NT 2001 0.1/Male + Pleural empyema [4]
chu Blood NT 2003 12.4/Male + Bacteremia, osteomyelitis, arthritis [4]
sta07 Abscess NT 2004 0.6/Male 2 Cutaneous abscess Current study
571 NP swab CT 2006 4.4/Female 2 Healthy child [3]
ksa13 NP swab ST 2006 NA 2 Healthy child [3]
ksa139 NP swab ST 2005 NA 2 Healthy child [3]
807 NP swab CT 2006 2.3/Female 2 Healthy child [3]
266 NP swab CT 2005 4.4/Female 2 Healthy child [3]
SA40 NP swab NT 2005 NA 2 Healthy child [3]
ksa174 NP swab ST 2006 NA 2 Healthy child [3]
Abbreviations: CT, central Taiwan; NA, not available; NP, nasopharyngeal; NT, northern Taiwan; ST, southern Taiwan.
doi:10.1371/journal.pone.0063210.t001
Figure 2. Comparisons of adherence to respiratory epithelial cells (a) and colonization in murine nares (b) in 2 representative
strains of the Taiwan clone (SA957) and the Asian-Pacific clone (SA40) of CA-MRSA ST59. The adherence experiment was repeated 6
times for SA957 and SA40 and repeated 3 times for SA113 and SA113DtagO. Each strain was replicated 4 times in each experiment. Significance of
differences was determined by two-way ANOVA. For murine nasal colonization, SA957 and SA40 were tested in 16 mice; SA113 and SA113 DtagO
were tested in 4 mice. Significance was determined by Mann–Whitney test.
doi:10.1371/journal.pone.0063210.g002
Comparison of CA-MRSA ST59 Clones
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different virulence profile of the 2 strains. A comprehensive
comparison of the 2 genomes at the nucleotide level is necessary to
address this issue, and is currently being undertaken.
The comparative genomic data suggest that, before acquiring
the PVL prophage and methicillin resistance, the progenitor of the
Taiwan clone might have undergone at least 2 recombination
episodes, ultimately resulting in the loss of 2 DNA fragments from
the Hlb-converting prophage, øSa3 [17,24]. These fragments
contained genes encoding immune evasion molecules such as
staphylokinase and enterotoxin P. Approximately 90% of S. aureus
strains carry the immune evasion cluster (IEC) with varying
combinations of scn (staphylococcal complement inhibitor), chp
(chemotaxis inhibitory protein), sea or sep, and sak [25]. The partial
loss of the IEC in the more virulent Taiwan clone suggests that the
molecules of IEC (e.g., sak and sep) do not contribute to the high
virulence of the Taiwan clone. Instead, loss or truncation of the
‘‘virulence genes’’ (e.g., sak) during evolution may increase
bacterial fitness in hosts, thus conferring a more virulent
phenotype [26]. The association of genome reduction with
increased virulence has been documented in comparative studies
Figure 3. Cytotoxic effect of an overnight bacterial culture
supernatant on human neutrophils. The cytotoxicity was com-
pared between PVL-positive strains and PVL-negative strains of CA-
MRSA of ST59 lineage.
doi:10.1371/journal.pone.0063210.g003
Figure 4. Comparison of Taiwan clone and Asian-Pacific clone virulence in a murine bloodstream infection model. Isolates of the
Taiwan clone (SA957) were more lethal at a lethal dosage (56107 CFU) (a), caused greater body weight loss (b), and greater bacterial loads in various
organs (c) at a non-lethal dosage (56106 CFU) than isolates of the Asian-Pacific clone (SA40). More prominent neutrophil aggregation was also seen
upon histologic examination of liver, kidney, and lung of mice infected with SA957 at a lethal dosage (d). Survival analysis was performed using a Log-
rank (Mantel–Cox) test (a). Comparisons of body weight changes of mice (b) and the bacterial loads in each organ (c) were performed using two-way
ANOVA and Mann–Whitney tests, respectively.
doi:10.1371/journal.pone.0063210.g004
Comparison of CA-MRSA ST59 Clones
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utilizing a variety of epidemic bacteria [27–29]. Indeed, this
hypothesis was supported by the observation that there was a
higher frequency and a greater magnitude of staphylokinase
production in staphylococcal isolates from nasal swabs than from
bloodstreams [30]. A clinical study further showed that sak-
deficient S. aureus strains were associated with significantly worse
clinical outcomes in patients with bacteremia compared to patients
infected with isolates producing high levels of staphylokinase [31].
These observations together also suggest that the IEC molecules
might contribute to the predominance of the Asian-Pacific clone in
the nasal MRSA isolates. Unfortunately, the in vitro assay of
adherence to respiratory cells and a murine nasal carriage model
failed to demonstrate a greater adherence and colonization ability
of the Asian-Pacific clone compared to the Taiwan clone. In an
animal model, this may be explained by murine non-susceptibility
to the IEC molecules [32,33]. Alternatively, the higher frequency
of the Asian-Pacific clone in the carriage CA-MRSA isolates may
be because of a greater expression of some surface proteins, which
were not thoroughly characterized in this study and further studies
will be warranted to confirm this speculation.
Human neutrophils represent the first line of defense against
bacterial invasion. S. aureus excretes a variety of exotoxins that are
cytotoxic to many types of host cells, including human neutrophils
[34]. PVL has been shown to be a potent cytotoxic factor for
human neutrophils [35]; however, the role of PVL in the
pathogenesis of CA-MRSA infection has been an issue of debate
due to controversial data generated by different study groups [36–
38]. Our data indicate that the supernatant of the Taiwan clone
induced a greater degree of neutrophil lysis than the Asian-Pacific
clone. Furthermore, the extent of neutrophil lysis appeared to be
correlated with the production of PVL in the Taiwan clone,
suggesting that PVL at least in part accounted for the cytotoxicity
to neutrophils in the ST59 CA-MRSA strains. PSM is a group of
novel cytolytic peptides of S. aureus. In addition to the cytotoxicity
to human neutrophils, the newly identified cytolysins have recently
been shown to have proinflammatory activity and are considered
essential virulence factors of CA-MRSA strains [39]. Indeed,
PSM-a, the most potent PSM cytolysin, showed significantly
higher expression in ST59 CA-MRSA strains than in the
nosocomial MRSA strains of a pandemic clone, ST239
(Figure 7b). However, the expression of PSM-a was not
significantly different in the Taiwan and Asian-Pacific clones,
suggesting that PSM-a plays only a minor role in human
neutrophil cytotoxicity for the CA-MRSA ST59 strains, and that
it does not account for the high pathogenicity of the Taiwan clone.
a-toxin is able to destroy a variety of host cells, including
respiratory epithelial cells, and has been shown to be essential for
the pathogenesis of staphylococcal pneumonia in mice [40]. The
significance of a-toxin in staphylococcal pneumonia was further
supported by the finding that immunization of mice against a-
toxin can protect them from S. aureus pneumonia [41]. The high
abundance of a-toxin production was also considered an
important factor for the enhanced virulence of the epidemic
CA-MRSA clone, USA300 [42]. Our data further indicates that,
compared to isolates from other sources, the expression of a-toxin
was significantly higher in CA-MRSA isolates causing pneumonia.
Intriguingly, all pneumonia isolates also harbored the PVL
genes. The significant association of PVL gene carriage and S.
aureus pneumonia has been noted in previous observations by our
group and others [4,43,44]. The role of PVL in staphylococcal
pneumonia was also shown in a study using a rabbit model of
necrotizing pneumonia [45]. Purified PVL was sufficient to recruit
and lyse PMN cells and damage lung tissue. Taken together, these
Figure 5. Distribution of selected virulence determinants in 82 random samples of clinical community-associated MRSA isolates
from Taiwanese children. The carriage rates of virulence determinants are compared between Taiwan clones and Asian-Pacific clones.
doi:10.1371/journal.pone.0063210.g005
Comparison of CA-MRSA ST59 Clones
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data suggest an important role of a-toxin and PVL in the
pathogenesis of CA-MRSA pneumonia.
In conclusion, comparison of 2 related epidemic CA-MRSA
clones of ST59 lineage indicated that the PVL-positive Taiwan
clone was a much more virulent and disease-prone clone
compared to the PVL-negative Asian-Pacific clone. The presence
of PVL and the higher expression of certain virulence molecules,
the most important of which is a-toxin, most likely contribute to
the high pathogenic potential of the Taiwan clone. Since PSM-a is
equally produced in isolates of both clones, it does not account for
the high virulence of the Taiwan clone. Comparative genomic
data suggest that the b-hemolysin-converting bacteriophage (øSa3)
genome was partially truncated in the Taiwan clone, but was
intact in the Asian-Pacific clone. This convergent evolution
resulting in gene loss and acquisition may contribute to the
success of the epidemic CA-MRSA clone in the past decade.
Methods
Ethics Statement
All animal experiments were approved by the ethics committee
of Chang Gung Memorial Hospital. Animal care and use was in
accordance with the institutional guidelines set forth by Chang
Gung Memorial Hospital. The cytotoxicity study of human
neutrophil was conducted in Mu¨nster University. Human blood
sample acquisition and cell isolations were conducted with the
approval of the local ethics committee (Ethik-Komission der
A¨rztekammer Westfalen-Lippe und der Medizinischen Fakulta¨t
der Westfa¨lischen Wilhelms-Universita¨t Mu¨nster). Human blood
samples were obtained from healthy blood donors, who provided
written informed consent for the collection of samples and
subsequent neutrophil isolation and analysis.
Figure 6. Microarray hybridization data for 14 isolates of CA-MRSA visualized using phage Sa3 genomes of MRSA 252. Relatedness
between the isolates is illustrated by the dendrogram. The isolates were grouped into 2 clusters, which is consistent with the pulsed typing grouping
result. Each of the color blocks represents a PCR product and is colored according to the normalized ratio, with color intensity dependent on the
signal for MRSA252 by using GeneSpring software. The bright colors (i.e., red, yellow, and orange) indicate that the genes are present, whereas the
dark colors (i.e., blue and gray) indicate that the genes are absent or divergent. The data suggest that the isolates of PVL-positive Taiwan clone carry a
truncated Sa3 prophage in which 2 DNA fragments are missing.
doi:10.1371/journal.pone.0063210.g006
Comparison of CA-MRSA ST59 Clones
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Bacterial Strains and Growth Condition
Fifteen MRSA strains with previously determined genotypes
were used in the current study. Of these, 8 strains were isolated
from hospitalized children with various clinical syndromes
between 2000 and 2007. We arbitrarily used strains with different
clinical manifestations, including cutaneous abscess, bone/joint
Figure 7. Expression of global regulators and virulence factors. Northern blot analysis did not show significant differences in the expressions
of RNAIII, SrrA, seaRS, spa, and hla for isolates of the Taiwan and Asian-Pacific clones (a). The production of PSM-a as measured by qPCR was also
similar for isolates of the 2 clones. The PSM-a production in a prevalent nosocomial MRSA clone in Taiwan, ST239 with type III SCCmec, is also
displayed, which is significantly less than the production in the 2 clones of ST59 lineage. (b). The expression of a-toxin was significantly higher in
isolates causing pneumonia than nasal isolates and isolates causing diseases other than pneumonia (c, d). The data represent 3 replicates for each
virulence factor (d).
doi:10.1371/journal.pone.0063210.g007
Comparison of CA-MRSA ST59 Clones
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infections, pneumonia, deep venous thrombosis, pyomyositis,
bacteremia, and shock (Table 1). The clinical strain selection
was not random because we intended to explore if a specific
disease entity was associated with any characteristics of the strain
(i.e., the harbored genes or the expression of particular factors).
Seven strains were randomly selected nasal isolates from healthy
children from a surveillance study between 2005 and 2008 [3].
The detailed clinical information and molecular types of the
strains are shown in Table 1 and Figure 1. Two representative
strains denoted the Taiwan clone (SA957) and Asian-Pacific clone
(SA40), which had been chosen for a separate whole genome-
sequencing project, were selected for characterization in the
experiments of adherence to respiratory epithelial cells, coloniza-
tion, and bloodstream infections in murine models. An additional
set of 82 randomly selected clinical MRSA isolates from pediatric
patients between 2003 and 2007 were screened for selected
virulence factors by using PCR (Methods S1, Table S2). Bacteria
were grown in liquid tryptic soy broth (TSB) (Sigma, Munich,
Germany) or on solid BM (1% Peptone, 0.5% yeast extract, 0.5%
NaCl, 0.1% K2HPO4, and 0.1% glucose) [46] unless otherwise
noted. A wall teichoic acid-deficient mutant (DtagO) and its
isogenic parent strain SA113 were included in the assay of
bacterial adherence to A549 cells and murine nasal colonization
model [47].
Assay of Bacterial Adherence to A549 Cells
A549 cells (26105 in 2 mL DMEM medium per well) were
prepared in 6-well plates and incubated overnight. The bacterial
isolates were grown in 15 mL TSB medium to an OD578 of 0.5,
washed, and resuspended in 15 mL PBS. Next, 100 mL of washed
bacteria were inoculated onto the A549 cells and centrifuged at
500 rpm for 5 min to enhance adhesion. The same volume of
bacteria was added to another plate with DMEM alone as a
control. After 1 h of incubation at 37uC, the wells were washed 3
times with PBS, and the cells were detached by adding 150 mL of
0.25% trypsin. The cells were further lysed by addition of Triton-
X100 at a concentration of 0.025%. The lysates were serially
diluted and plated out for counting of bacterial numbers. SA113,
SA113DtagO, and representative strains for the Taiwan clone
(SA957) and the Asian-Pacific clone (SA40) were tested in this
assay. Each strain was replicated 4 times in each experiment. The
experiment was repeated 6 times for SA957 and SA40 and 3 times
for SA113 and SA113 DtagO.
Murine Nasal Colonization Study
The murine nasal colonization model was modified from a
previously published protocol [48]. The overnight-cultured
bacteria were diluted 1:100 and grown by shaking at 150 rpm to
an OD578 of 0.8 in TSB medium at 37uC. A predetermined
volume of bacterial suspension equivalent to 16108 CFU was
precipitated by centrifugation, washed with PBS, and then
resuspended in 10 mL PBS. Six- to 8-week-old C57BL/6 mice
were purchased from the National Laboratory Animal Center.
Drinking water containing streptomycin (5 g per 1 L water) was
provided for at least 48 h before inoculation and through the
whole study. Next, 10 mL of a bacterial suspension containing
16108 CFU of bacteria was pipetted slowly onto the nares of the
mice without actually touching the pipette tip to the nose. The
animals were killed using CO2 and evaluated for nasal carriage of
bacteria 7 d after inoculation. The external nasal region was
wiped with 70% ethanol, excised from the inside front of mouth,
dissected with sterile scissors, and vortexed vigorously in 1 mL
PBS. The suspension was serially diluted and plated out for
counting of bacterial numbers. Baird–Parker medium (BD-
Taiwan, Becton, Dickinson and Company) was used for selection
of S. aureus strains. SA957 and SA40 were tested in 16 mice. SA113
and SA113DtagO were tested in 4 mice.
Murine Sepsis Model
The murine sepsis model was performed in accordance with the
method described previously with some modifications. Briefly, 6-
to 8-week-old C57BL/6 mice were injected with the indicated S.
aureus strain at a lethal dosage of 56107 CFU or a non-lethal
dosage of 56106 CFU via the jugular vein. At the lethal dosage,
each group contained 8 mice. At the non-lethal dosage, 9 mice
were infected with SA957 and 8 mice were infected with SA40.
The mice infected with the lethal dosage were observed at 3 h
intervals for symptoms of hunched posture, decreased activity,
ruffled fur, and labored breathing. The mice were killed if they
were too sick to eat or drink, or if they became immobile. All
surviving mice were killed at 48 h. At the time of death, kidneys,
liver, and lungs were removed and fixed in 10% neutral-buffered
formalin. After dehydration using a graded series of ethanol, the
tissues were embedded in paraffin, sectioned, and stained with
hematoxylin and eosin. The mice infected with the non-lethal
dosage were observed and weighed every 12 h for 7 d. All animals
were killed at day 7, and the kidneys, liver, spleen, and lungs were
removed for homogenization and determination of bacterial load.
Preparation of Human Neutrophils and Cytotoxicity
Assay
Human neutrophils were freshly isolated from Na citrate-
treated blood of healthy adult volunteers. Dextran-sedimentation
and density gradient centrifugation using Ficoll-Paque Plus
(Amersham Bioscience) was used for neutrophil isolation, accord-
ing to the manufacturer’s instruction. Neutrophils were resus-
pended at a final density of 16106 cells/0.5 mL in RPMI 1640
culture medium (PAA Laboratories GmbH) supplemented with
10% heat-inactivated FCS (PAA Laboratories GmbH). Neutro-
phils were used immediately for cytotoxicity assays.
All cytotoxicity experiments were performed in 24-well plates,
and neutrophils were incubated with bacterial supernatants of
overnight cultures grown in brain-heart infusion broth in a rotary
shaker. Supernatants were sterile-filtered and added to the cell
culture medium at a final concentration of 30%. All incubations
were performed at 37uC in humidified air with 5% CO2.
Measurement of cell death was performed after 1 h of incubation,
followed by washing and staining of cells with propidium iodide.
The cells were analyzed in a FACS caliber flow cytometer.
PVL Blot
Detection of PVL (lukF and lukS) was performed following
methods that were previously described [35]. Anti-PVL antibodies
were raised in rabbits, followed by incubation with anti-rabbit
alkaline phosphatase-conjugated antibodies, and bands were
visualized colorimetrically using avidin alkaline phosphatase. To
detect PVL amounts in bacterial culture supernatants, bacteria
were grown in 5 mL of brain-heart infusion medium, supernatants
were sterile-filtered, and used for western blot analysis. The
amount of PVL was determined semi-quantitatively using 5
categories: 2, no PVL production; +/2, borderline; +, low; ++,
high; and +++, very high PVL production.
Genomic Microarray
Comparative genomics was performed using a whole-genome S.
aureus DNA microarray containing 3,623 probes, which was
designated and validated by Witney et al. The 3,623 probes on
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microarray chip represented every predicted ORF of 7 whole-
genome sequenced S. aureus strains (MRSA252, N315, Mu50,
COL, 8325, MW2, and MSSA476), and was the most compre-
hensive S. aureus microarray chip available when this study was
carried out. Five micrograms each of genomic DNA from the test
strain and reference strain (MRSA252) was labeled with Cy3 and
Cy5, respectively, and competitively hybridized on the microarray
slide using methods as previously described. Slides were scanned
and data were extracted by GenePix. The microarray data were
loaded into GeneSpring (Agilent Technologies) for normalization
and analysis. An arbitrary cutoff of 2-fold was used to identify
genes that were specific to a single strain. Genes with a ratio
greater than the upper cutoff (2.0) were deemed specific to the test
strain, genes with a ratio less than the lower cutoff were considered
specific to the reference strain, and genes with ratio between 0.5
and 2 were classified as present in both strains.
RNA Extraction and Northern Blot
A 1:10 diluted overnight culture was subcultured for 3 h at
37uC, harvested, and subjected to bacterial cell wall lysis using
10 mg of lysostaphin (Sigma) for 10 min at 37uC. Total RNA was
isolated using the Trizol method [49]. Digoxygenin-labeled RNA
probes were prepared by in vitro transcription with T7 RNA
polymerase using PCR-generated fragments as templates. The
PCR fragments were generated using chromosomal DNA of S.
aureus COL. For northern blot analysis, 10 mg of total RNA (5 mg
for RNAIII detection) were separated in a 1% agarose gel
containing 20 mM morpholinepropanesulfonic acid (MOPS),
5 mM sodium acetate, 1 mM EDTA, and 1.85% formaldehyde
at pH 7.0. The gel was blotted onto a nylon membrane with 206
SSPE (3 M NaCl, 0.2 M NaH2PO4, and 0.02 M EDTA pH 7.4)
by using a vacuum blotter. After 4 h, RNA was fixed on the
membrane by UV cross-linking for 1 min. The membrane was
stained with methylene blue to visualize 16 and 23S rRNA bands
to control for successful blotting and the existence of equal
amounts of total RNA in each lane. Band density was digitalized
using AlphaEaseFC software (Alpha Innotech Corp., CA, USA).
Reverse Transcription and Real-time Quantitative PCR for
the Detection of PSM-a Production
Purified RNA (1 mg) was used for reverse transcription (RT) by
using the SuperScript III first-strand synthesis system (Invitrogen).
This cDNA product was used for real-time quantitative PCR (real-
time qPCR) according to the iQ SYBR Green Supermix (Bio-Rad
Laboratories, CA, USA) manufacturer’s instructions, in which a
25 mL reaction mixture contained primers (200 nM in each). The
primers used were as follows: PSM-a1-F (59–ATGGGTAT-
CATCGCTGGCATCATTA) and PSM-a 3-R (59–AC-
CTAAAAATTTACCAAGTAAATCT) for amplifying the PSM-
a transcript; 16S rRNA-F (59–TCCTACGGGAGGCAGCAGT)
and 16S rRNA-R (59–GGACTACCAGGGTATC-
TAATCCTGTT) for a reference control. The reaction was
performed in the iQ5 Multicolor real-time PCR detection system
with iQ5 optical system software (Bio-Rad Laboratories, USA),
and the reaction conditions were 95uC for 3 min, 1 cycle; 95uC for
10 s, 60uC for 30 s, 40 cycles; 95uC for 1 min, 50uC for 1 min, 1
cycle; then starting from 50uC for 10 s for melt curve with a 0.5uC
increase after each cycle, 91 cycles.
Statistics
The significances of strain differences in murine nasal coloni-
zation (Figure 2b), bacterial loads in each organ of mice infected
with a non-lethal dosage of bacteria (Figure 4c), and the expression
of various virulence factors or global regulators (Figure 7a–c) were
determined using non-parametric Mann–Whitney tests. The
statistical significance of differences in the adherence to A549
cells (Figure 2a) and the body weight changes of mice infected with
non-lethal dosages of bacteria (Figure 4b) in different strains was
determined using two-way analysis of variance (ANOVA) tests.
Survivals of septic mice infected with lethal dosages of bacteria
were compared between different strains by using a Log-rank
(Mantel-Cox) test. The significances of differences between the
different strains in virulence determinants were detected using a t-
test. All data were analyzed using GraphPad Prism 5 for Windows
(GraphPad Software, La Jolla, CA, USA).
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